Fracture Incidence in Graves' Disease: A Population-Based Study

Area of Science:

• Endocrinology
• Bone Metabolism
• Epidemiology

Background:

• Hyperthyroidism, particularly Graves' disease (GD), is linked to increased bone turnover and potential bone mineral density loss.
• Previous population studies show mixed results regarding fracture risk in hyperthyroid patients, necessitating further investigation.
• Graves' disease is the most common cause of hyperthyroidism, making it a key focus for understanding bone health implications.

Purpose of the Study:

• To investigate the specific fracture risk in patients diagnosed with Graves' disease.
• To analyze skeletal complication risks, including fractures, in a large cohort of GD patients.
• To compare fracture rates between GD patients and matched controls from the general population.

Main Methods:

• Retrospective cohort study design utilizing Swedish national registries for patient data and drug/treatment information.
• Inclusion of 2134 incident Graves' disease patients and 21,261 matched controls, followed for 16-18 years post-diagnosis.
• Statistical analysis using Cox proportional hazards models to estimate hazard ratios (HR) and confidence intervals (CI) for fracture risk.

Main Results:

• No significant overall difference in total fracture rates was observed between Graves' disease patients and controls.
• Adjusted analysis revealed a significantly higher vertebral fracture rate in male GD patients over 52 years old (HR = 2.83).
• Graves' disease patients received more osteoporosis and corticosteroid treatments, but these did not fully explain the observed fracture risk differences.

Conclusions:

• Total fracture risk is not elevated in the general Graves' disease population compared to controls.
• Older male patients with Graves' disease exhibit an increased risk of vertebral fractures.
• Patients with treated Graves' disease are more likely to receive osteoporosis treatments than the general population.